NEXENTIS TECHNOLOGIES INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $2.51M.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $300.00K, a 67.98% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $1.25M.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $937.00K.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, new issues for fiscal 2024 was $2.71M, a 965.35% increase from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, new issues for fiscal 2023 was $254.00K, a 93.81% decline from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, new issues for fiscal 2022 was $4.10M, a 60.76% decline from fiscal 2021.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, new issues for fiscal 2021 was $10.46M, a 2887.96% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $2.51M 10-Q · filed 2026-08-13 | |
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $2.71M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.25M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $937.00K 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $40.00K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $254.00K 10-K · filed 2025-03-31 | |
| 2022-12-31 | $4.10M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $4.10M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $10.46M 10-K · filed 2023-03-27 | |
| 2021-06-30 | $10.46M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $350.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $250.00K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $840.69K 10-K · filed 2021-03-29 |
| 2019-09-30 | $99.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | |
| 2019-06-30 | $284.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | |
| 2019-03-31 | $456.67K 10-Q · filed 2020-05-15 | |
| 2018-12-31 | $914.33K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |